AIMS: To evaluate studies on the use of positron emission tomography with the glucose analog 18F-fluoro-deoxyglucose (FDG-PET) for the preoperative staging of patients with non-small cell lung cancer (NSCLC) according to the criteria of evidence based medicine and to discuss the cost-effectiveness of the technique. METHODS: Clinical studies published between 1995 and 2002 on the preoperative staging of non-small cell lung cancer were used for this analysis...
Keywords: EbM, nicht kleinzelliges Bronchialkarzinom, Staging, 18 F-FDG-PET, Kosten/Nutzenanalyse
01/2003 | Nuklearmedizin, SchattauerAIM: In this prospective study, reliability of integrated 18F-FDG PET/CT for staging of NSCLC was evaluated and compared to MDCT or PET alone...
Keywords: NSCLC, PET/CT, PET, MDCT, T-staging
01/2007 | Nuklearmedizin, Schattauer